US Stock MarketDetailed Quotes

Biomarin Pharmaceutical (BMRN)

Watchlist
  • 55.070
  • -1.010-1.80%
Close Jan 15 16:00 ET
10.58BMarket Cap20.47P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biomarin Pharmaceutical (BMRN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
4.08%776.13M
15.92%825.41M
14.84%745.15M
17.97%2.85B
15.65%747.31M
28.28%745.74M
19.61%712.03M
8.79%648.83M
15.42%2.42B
20.22%646.21M
Operating revenue
4.08%776.13M
15.92%825.41M
14.84%745.15M
17.97%2.85B
15.65%747.31M
28.28%745.74M
19.61%712.03M
8.79%648.83M
15.42%2.42B
20.22%646.21M
Cost of revenue
-25.67%140.09M
15.05%150.09M
21.07%151.56M
9.05%580.24M
-1.30%136.14M
47.18%188.46M
-0.12%130.46M
-7.60%125.18M
5.77%532.06M
-5.94%137.93M
Gross profit
14.13%636.05M
16.12%675.32M
13.36%593.59M
20.48%2.27B
20.24%611.17M
22.94%557.28M
25.16%581.57M
13.60%523.65M
18.46%1.89B
30.03%508.28M
Operating expense
53.97%682.73M
-13.58%398.45M
-16.96%369.68M
5.77%1.8B
-6.48%449.8M
16.81%443.41M
15.53%461.09M
11.70%445.19M
10.79%1.7B
19.24%480.98M
Selling and administrative expenses
5.88%268.4M
-11.67%232.3M
-8.76%206.1M
13.07%1.01B
2.74%266.6M
46.87%253.5M
27.61%263M
7.05%225.9M
8.41%892.4M
20.75%259.5M
-Selling and marketing expense
20.57%131.3M
-0.57%122.1M
-14.15%102.5M
-2.40%476.7M
-5.71%125.6M
-10.66%108.9M
6.23%122.8M
--119.4M
8.46%488.4M
6.90%133.2M
-General and administrative expense
-5.19%137.1M
-21.40%110.2M
-2.72%103.6M
31.76%532.3M
11.64%141M
185.21%144.6M
54.91%140.2M
--106.5M
8.34%404M
39.87%126.3M
Research and development costs
121.46%409.48M
-12.23%161.31M
-22.57%158.73M
0.06%747.18M
-15.87%173.51M
-3.35%184.9M
3.62%183.79M
19.29%204.99M
14.96%746.77M
19.39%206.25M
Depreciation amortization depletion
-3.23%4.85M
-66.11%4.85M
-66.10%4.85M
-30.39%43.3M
-36.33%9.69M
-68.06%5.01M
-8.48%14.3M
-8.76%14.3M
-0.96%62.2M
-3.03%15.23M
-Depreciation and amortization
-3.23%4.85M
-66.11%4.85M
-66.10%4.85M
-30.39%43.3M
-36.33%9.69M
-68.06%5.01M
-8.48%14.3M
-8.76%14.3M
-0.96%62.2M
-3.03%15.23M
Operating profit
-140.99%-46.68M
129.79%276.87M
185.35%223.91M
155.23%474.2M
491.06%161.37M
54.52%113.87M
83.76%120.48M
25.74%78.47M
223.62%185.79M
319.17%27.3M
Net non-operating interest income expense
1.26%15.28M
-0.39%16.15M
2.10%16.15M
41.51%62.15M
1.18%15.04M
26.12%15.09M
83.03%16.21M
91.97%15.82M
1,110.95%43.92M
123.60%14.86M
Non-operating interest income
-1.10%17.85M
-4.84%18.83M
-1.82%19.01M
28.36%74.88M
-2.02%17.68M
14.70%18.05M
56.87%19.79M
62.15%19.37M
223.49%58.34M
107.16%18.04M
Non-operating interest expense
-13.11%2.58M
-25.04%2.68M
-19.28%2.86M
-10.74%12.34M
-13.03%2.25M
-21.46%2.97M
-4.82%3.57M
-4.21%3.55M
0.07%13.82M
75.99%2.59M
Total other finance cost
----
----
----
-34.18%391K
----
----
----
----
0.17%594K
----
Other net income (expense)
-6.77%5.09M
206.76%4.83M
-117.34%-1.95M
113.95%5.33M
65.47%-6.87M
768.67%5.46M
-25.30%-4.53M
181.13%11.27M
-142.40%-38.22M
-95.96%-19.9M
Special income (charges)
--0
--0
--0
--10M
--0
--0
--0
--10M
--0
--0
-Less：Restructuring and merger&acquisition
----
----
----
--0
----
----
----
----
--0
----
-Gain on sale of property,plant,equipment
--0
--0
--0
--10M
--0
--0
--0
--10M
--0
--0
Other non- operating income (expenses)
-6.77%5.09M
206.76%4.83M
-254.22%-1.95M
87.78%-4.67M
65.47%-6.87M
768.67%5.46M
-25.30%-4.53M
109.12%1.27M
-183.87%-38.22M
-108.27%-19.9M
Income before tax
-119.58%-26.32M
125.43%297.87M
125.58%238.09M
187.31%541.76M
777.73%169.64M
222.64%134.44M
86.61%132.14M
85.96%105.55M
26.07%188.56M
210.08%19.33M
Income tax
-84.42%4.42M
129.69%57.34M
210.35%52.4M
449.31%114.9M
4,364.89%44.7M
2,096.82%28.36M
69.00%24.96M
185.94%16.89M
160.99%20.92M
93.95%-1.05M
Net income
-128.98%-30.74M
124.43%240.53M
109.43%185.69M
154.62%426.86M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
Net income continuous Operations
-128.98%-30.74M
124.43%240.53M
109.43%185.69M
154.62%426.86M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
Minority interest income
Net income attributable to the parent company
-128.98%-30.74M
124.43%240.53M
109.43%185.69M
154.62%426.86M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-128.98%-30.74M
124.43%240.53M
109.43%185.69M
154.62%426.86M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
Basic earnings per share
-128.57%-0.16
123.21%1.25
106.38%0.97
152.81%2.25
500.00%0.66
166.67%0.56
86.67%0.56
74.07%0.47
17.11%0.89
8,315.09%0.11
Diluted earnings per share
-129.09%-0.16
123.64%1.23
106.52%0.95
154.02%2.21
481.82%0.64
161.90%0.55
89.66%0.55
70.37%0.46
16.00%0.87
8,315.09%0.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 4.08%776.13M15.92%825.41M14.84%745.15M17.97%2.85B15.65%747.31M28.28%745.74M19.61%712.03M8.79%648.83M15.42%2.42B20.22%646.21M
Operating revenue 4.08%776.13M15.92%825.41M14.84%745.15M17.97%2.85B15.65%747.31M28.28%745.74M19.61%712.03M8.79%648.83M15.42%2.42B20.22%646.21M
Cost of revenue -25.67%140.09M15.05%150.09M21.07%151.56M9.05%580.24M-1.30%136.14M47.18%188.46M-0.12%130.46M-7.60%125.18M5.77%532.06M-5.94%137.93M
Gross profit 14.13%636.05M16.12%675.32M13.36%593.59M20.48%2.27B20.24%611.17M22.94%557.28M25.16%581.57M13.60%523.65M18.46%1.89B30.03%508.28M
Operating expense 53.97%682.73M-13.58%398.45M-16.96%369.68M5.77%1.8B-6.48%449.8M16.81%443.41M15.53%461.09M11.70%445.19M10.79%1.7B19.24%480.98M
Selling and administrative expenses 5.88%268.4M-11.67%232.3M-8.76%206.1M13.07%1.01B2.74%266.6M46.87%253.5M27.61%263M7.05%225.9M8.41%892.4M20.75%259.5M
-Selling and marketing expense 20.57%131.3M-0.57%122.1M-14.15%102.5M-2.40%476.7M-5.71%125.6M-10.66%108.9M6.23%122.8M--119.4M8.46%488.4M6.90%133.2M
-General and administrative expense -5.19%137.1M-21.40%110.2M-2.72%103.6M31.76%532.3M11.64%141M185.21%144.6M54.91%140.2M--106.5M8.34%404M39.87%126.3M
Research and development costs 121.46%409.48M-12.23%161.31M-22.57%158.73M0.06%747.18M-15.87%173.51M-3.35%184.9M3.62%183.79M19.29%204.99M14.96%746.77M19.39%206.25M
Depreciation amortization depletion -3.23%4.85M-66.11%4.85M-66.10%4.85M-30.39%43.3M-36.33%9.69M-68.06%5.01M-8.48%14.3M-8.76%14.3M-0.96%62.2M-3.03%15.23M
-Depreciation and amortization -3.23%4.85M-66.11%4.85M-66.10%4.85M-30.39%43.3M-36.33%9.69M-68.06%5.01M-8.48%14.3M-8.76%14.3M-0.96%62.2M-3.03%15.23M
Operating profit -140.99%-46.68M129.79%276.87M185.35%223.91M155.23%474.2M491.06%161.37M54.52%113.87M83.76%120.48M25.74%78.47M223.62%185.79M319.17%27.3M
Net non-operating interest income expense 1.26%15.28M-0.39%16.15M2.10%16.15M41.51%62.15M1.18%15.04M26.12%15.09M83.03%16.21M91.97%15.82M1,110.95%43.92M123.60%14.86M
Non-operating interest income -1.10%17.85M-4.84%18.83M-1.82%19.01M28.36%74.88M-2.02%17.68M14.70%18.05M56.87%19.79M62.15%19.37M223.49%58.34M107.16%18.04M
Non-operating interest expense -13.11%2.58M-25.04%2.68M-19.28%2.86M-10.74%12.34M-13.03%2.25M-21.46%2.97M-4.82%3.57M-4.21%3.55M0.07%13.82M75.99%2.59M
Total other finance cost -------------34.18%391K----------------0.17%594K----
Other net income (expense) -6.77%5.09M206.76%4.83M-117.34%-1.95M113.95%5.33M65.47%-6.87M768.67%5.46M-25.30%-4.53M181.13%11.27M-142.40%-38.22M-95.96%-19.9M
Special income (charges) --0--0--0--10M--0--0--0--10M--0--0
-Less：Restructuring and merger&acquisition --------------0------------------0----
-Gain on sale of property,plant,equipment --0--0--0--10M--0--0--0--10M--0--0
Other non- operating income (expenses) -6.77%5.09M206.76%4.83M-254.22%-1.95M87.78%-4.67M65.47%-6.87M768.67%5.46M-25.30%-4.53M109.12%1.27M-183.87%-38.22M-108.27%-19.9M
Income before tax -119.58%-26.32M125.43%297.87M125.58%238.09M187.31%541.76M777.73%169.64M222.64%134.44M86.61%132.14M85.96%105.55M26.07%188.56M210.08%19.33M
Income tax -84.42%4.42M129.69%57.34M210.35%52.4M449.31%114.9M4,364.89%44.7M2,096.82%28.36M69.00%24.96M185.94%16.89M160.99%20.92M93.95%-1.05M
Net income -128.98%-30.74M124.43%240.53M109.43%185.69M154.62%426.86M513.22%124.94M162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M
Net income continuous Operations -128.98%-30.74M124.43%240.53M109.43%185.69M154.62%426.86M513.22%124.94M162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M
Minority interest income
Net income attributable to the parent company -128.98%-30.74M124.43%240.53M109.43%185.69M154.62%426.86M513.22%124.94M162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -128.98%-30.74M124.43%240.53M109.43%185.69M154.62%426.86M513.22%124.94M162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M
Basic earnings per share -128.57%-0.16123.21%1.25106.38%0.97152.81%2.25500.00%0.66166.67%0.5686.67%0.5674.07%0.4717.11%0.898,315.09%0.11
Diluted earnings per share -129.09%-0.16123.64%1.23106.52%0.95154.02%2.21481.82%0.64161.90%0.5589.66%0.5570.37%0.4616.00%0.878,315.09%0.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -